The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

The U.S. faces a potential 'Quad-emic' with rising cases of flu, COVID, RSV, and norovirus. Older adults, especially those ...

Respiratory viruses are continuing to spread across the United States and such activity "is expected to continue for several ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

However, certain groups, particularly older adults and infants under six months old, may develop more severe symptoms and could require hospitalization. The CDC said that symptoms of RSV infection ...

RSV is a common, but highly infectious, respiratory virus that affects the breathing system, particularly in young children ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...